Retraction: Hsa-miR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of c-Met

Chengcao Sun; Ming Sang; Shujun Li; Xiaodong Sun; Cuili Yang; Yongyong Xi; Liang Wang; Feng Zhang; Yongyi Bi; Yunfeng Fu; Dejia Li

doi:10.18632/oncotarget.28329

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Retraction:

Retraction: Hsa-miR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of c-Met

PDF | How to cite

Oncotarget. 2023; 14:50-50. https://doi.org/10.18632/oncotarget.28329

Metrics: PDF 848 views | ?

Chengcao Sun^1,3,*, Ming Sang^2,*, Shujun Li^1,4, Xiaodong Sun², Cuili Yang¹, Yongyong Xi¹, Liang Wang¹, Feng Zhang¹, Yongyi Bi¹, Yunfeng Fu⁵ and Dejia Li¹

¹Department of Occupational and Environmental Health, School of Public Health, Wuhan University, 430071 Wuhan, P.R. China
²Central Laboratory of the Fourth Affiliated Hospital in Xiangyang, College of Basic Medical Sciences, Hubei Key Laboratory of Wudang Local Chinese Medicine Research, Hubei University of Medicine, 442000 Shiyan, P.R. China
³Institute of Global Health, Wuhan University, 430071 Wuhan, P.R. China
⁴Wuhan Hospital for the Prevention and Treatment of Occupational Diseases, 430071 Wuhan, P.R. China
⁵The Third Xiang-ya Hospital of Central South University, 410013 Changsha, P.R. China
^*These authors have contributed equally to this work

Published: January 26, 2023

Copyright: © 2023 Sun et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been retracted: Oncotarget requested the original data for this paper to address concerns regarding image duplication. The authors were unable to retrieve the data. As a result, all authors have agreed to the retraction of this paper from Oncotarget.

Original article: Oncotarget. 2015; 6:39756–39792. DOI: https://doi.org/10.18632/oncotarget.5476

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28329

Publication Alerts

Post-Publication Promotion

Publication Discount

Retraction:

Retraction: Hsa-miR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of c-Met